Sales of biotech hair growth line Divine Skin go through the roof
The company put the increase in sales down to investments in production coupled with ‘massive demand’ for the product line, which includes a best-selling shampoo and hair growth treatments.
“Although Q1 delivered a stellar number – made possible by numerous improvements in logistics and fulfillment – we are not yet satisfied and certainly not resting on our accomplishments,” said CEO Daniel Khesin.
“Divine Skin can grow even faster, and coming quarters will be proof of that.”
Further expansion from international markets
The company will be looking to further expand its sales by turning to international markets, and in line with this it recently appointed Robin Powell to its executive board, in charge of global development.
Powell is charged with the global development of the hair loss treatment, and will tackle each of the major global regions – Latin America, Asia Pacific and Europe – in an effort to increase the brand’s footprint worldwide.
“We have just scratched the surface of an enormous market; the potential is endless. With the four new distribution agreements just announced, I have no doubt that shareholders will be enormously satisfied for many years to come,” said Khesin.
Salon and salon supplier agreements
The four agreements have included beauty salon and salon suppliers across the US, including Salon Services and Supplies, Sweis, The Salon Center and Salon Only Sales – deals that were largely brokered by Powell.
The Divine Skin line is aimed at treating androgenic alopecia, or male pattern hair loss, which is the most common form of hair loss and is said to affect around 50 percent of men aged over 40.
DS Laboratories, Divine Skin’s first brand, also unveiled two new over-the-counter products late last year; Revita.EPS - a treatment to grow eyelashes 25 percent longer in just 4 weeks; and Revita.COR - a hair-growth-stimulating conditioner with bio-adhesive properties.
